Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial (Q38447818)
Jump to navigation
Jump to search
scientific article published on May 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial |
scientific article published on May 2004 |
Statements
1 reference
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial (English)
1 reference
1 reference
David R Gandara
1 reference
Primo N Lara
1 reference
Karen Giselle Chee
1 reference
Christopher Ruel
1 reference
Frederick J Meyers
1 reference
Carl R Gray
1 reference
Regina Gandour Edwards
1 reference
Paul H Gumerlock
1 reference
Przemyslaw Twardowski
1 reference
James H Doroshow
1 reference
1 May 2004
1 reference
1 reference
Identifiers
1 reference